Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 0.00%
March 31, 2026 0.00%
December 31, 2025 -2.00%
September 30, 2025 -2.00%
June 30, 2025 -2.00%
March 31, 2025 2.00%
December 31, 2024 0.00%
September 30, 2024 -18.00%
June 30, 2024 4.00%
March 31, 2024 6.00%
December 31, 2023 6.00%
September 30, 2023 10.00%
June 30, 2023 4.00%
March 31, 2023 8.00%
December 31, 2022 6.00%
September 30, 2022 13.98%
June 30, 2022 97.71%
March 31, 2022 89.83%
December 31, 2021 98.14%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 37.19%
December 31, 2020 0.00%
September 30, 2020 0.00%
June 30, 2020 0.00%
Date Value
March 31, 2020 0.00%
December 31, 2019 -87.04%
September 30, 2019 7.96%
June 30, 2019 -29.92%
March 31, 2019 -20.24%
December 31, 2018 21.09%
September 30, 2018 27.27%
June 30, 2018 16.59%
March 31, 2018 -12.18%
December 31, 2017 0.00%
September 30, 2017 68.24%
June 30, 2017 -34.53%
March 31, 2017 -24.80%
December 31, 2016 0.00%
September 30, 2016 -179.8%
June 30, 2016 37.53%
March 31, 2016 32.51%
December 31, 2015 4.32%
September 30, 2015 19.41%
June 30, 2015 -1.83%
March 31, 2015 73.84%
December 31, 2014 -156.6%
September 30, 2014 53.36%
June 30, 2014 -16.85%
March 31, 2014 -11.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 69.90%
Integrated BioPharma, Inc. 0.29%
Nevis Brands, Inc. --
Functional Brands, Inc. 59.89%
Cyanotech Corp. 42.38%

Gross Profit Margin (Quarterly) Related Metrics